Key Issues in FDA & FTC Regulation of Dietary Supplements 2013
30 May 2013
Webinar
Key Topics
Recent FDA enforcement action on dietary supplement GMPs
Overview of dietary supplement regulation
Understanding when claims convert a dietary supplement into a drug and the consequences of the resulting unapproved new drug status
Changes in FDA’s New Dietary Ingredient (NDI) requirements
The FTC’s decision in POM Wonderful and its implications for claims substantiation
Who should Attend
C-Suite / Senior Executives from dietary supplement companies involved in:
Quality Assurance
Manufacturing
Compliance
Regulatory Affairs
Marketing
Sales
Scientific Affairs
Legal
Clinical
Past Events
Key Issues in FDA & FTC Regulation of Dietary Supplements 2013 - 30 May 2013, Webinar (37968)
Key Issues in FDA & FTC Regulation of Dietary Supplements 2026
Important
Please, check "Key Issues in FDA & FTC Regulation of Dietary Supplements" official website for possible changes, before making any traveling arrangements
